FULL DETAILS (Read-only)

CTRI Number  CTRI/2009/091/001067 [Registered on: 17/02/2010]
Last Modified On: 26/09/2014
Post Graduate Thesis   
Type of Trial  Interventional 
Type of Study
Modification(s)  
Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study
Modification(s)  
Phase III clinical trial for Evaluation of Efficacy and Safety of IN-PHARM-002 in Comparison with Ibuprofen in adult patients with acute painful soft tissue injury. 
Scientific Title of Study
Modification(s)  
AN OPEN LABEL, RANDOMIZED, PARALLEL GROUP, PROSPECTIVE, MULTICENTRE CLINICAL TRIAL FOR EVALUATION OF EFFICACY AND SAFETY OF IN-PHARM-002 IN COMPARISON WITH IBUPROFEN IN ADULT PATIENTS WITH ACUTE PAINFUL SOFT TISSUE INJURY 
Secondary IDs if Any
Modification(s)  
Secondary ID  Registry 
CT/IN-PHARM-002/APASTI/III/09  DCGI 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Modification(s)  
Name  Dr Rajendra C Rane 
Address  Intas Pharmaceuticals Chinubhai Centre Ashram Road, Ahmedabad
As above
Ahmadabad
GUJARAT
380009
India 
Phone  26576655  
Fax  26576616  
Email  rane@intaspharma.com  
 
Details Contact Person
Scientific Query

Modification(s)  
Name  Dr H V Barkate 
Address  Medical Services Intas Pharmaceuticals Ltd Chinubhai Centre Ashram road
As above
Ahmadabad
GUJARAT
380009
India 
Phone  66117401  
Fax  26576616  
Email  drbarkate@intaspharma.com  
 
Details Contact Person
Public Query

Modification(s)  
Name  Dr HV Barkate 
Address  Medical Services, Intas Pharmaceuticals Ltd. Chinubhai centre Ahmedabad
As above
Ahmadabad
GUJARAT
380009
India 
Phone  66117401  
Fax  26576616  
Email  drbarkate@intaspharma.com  
 
Source of Monetary or Material Support
Modification(s)  
Intas Pharmaceuticals Limited, Ahmedabad  
 
Primary Sponsor
Modification(s)  
Name  Intas Pharmaceuticals Limited  
Address  2nd Floor Chinubhai Center Ashram Road Ahmedabad 380009  
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor
Modification(s)  
Name  Address 
Nil  Nil 
 
Countries of Recruitment
Modification(s)  
  India  
Sites of Study
Modification(s)  
No of Sites = 15  
Contact Person  Name of Site  Site Address  Phone/Fax/Email 
Dr. Mohan Mantri  AKANKSHA ORTHO.HOSPITAL  5A2, AKANKSHA ORTHO.HOSPITAL ,VIGYAN NAGAR -300045
Kota
 
9828044007;0744-2421369, 2427359

 
Dr. Sunil Singh  Anjali Dental Clinic, Bhopal  Anjali Dental Clinic; Dr. SK Singh, ,341-Rachananagar, Post Govindpura,-462023
Bhopal
 
9425600200

sunil_anjali2@yahoo.com 
Dr. Minesh Modi  Ashakta Ashram Hospital  ASHAKTA ASHRAM HOSPITAL, ,Rampura-
Surat
 
9426030893

drminesh@yahoo.com 
Dr. DK Jindel  B-51 Harimarg, Jaipur  Malviya Nagar,-
Jaipur
 
09829213212

dineshjindel@yahoo.co.in 
Dr Rakesh Shivhare  CHL APPOLLO HOSPITAL  CHL-Apollo Hospitals,,A. B. Road, Near L. I. G Triangle,-452008
Indore
 
9826680273, 0731-4072550 Ext 229
0731-2549095
madhu@chl_apollo.com 
Dr. Shailesh Shah  Dr. SS Surgical Hospital  Dr. SS Surgical Hospital, Vijay Tower,,Opp. Abad Dairy, Kankaria Rd. Maninagar, -
Ahmadabad
 
9824044443

ssshec@hotmail.com 
Dr Narendra Patidar  Gokuldas hospital  202 Raunak Plaza, South Tukoganj,Opposite Nath Mandir, -
Indore
 
9827039911

narendrapatidar103@yahoo.in 
Dr Apoorva Chaudhary  Indore  Amit Chambers, Near Pooja Dairy,MY main road,-
Indore
 
9827247787

apoorvaneepa @yahoo.in 
Dr. Ashok Meghwal  JLN Medical College, Ajmer  Aakansha, Kokil Kunj,,Pal Vichala Road, -
Ajmer
 
9829099949

 
Dr. Pritesh Patel  Raj Surgical Hospital  Raj Surgical Hospital, Maruti Complex, ,Drive In Rd. Memnagar, -380056
Ahmadabad
 
9825322901

devyugpritusha@yahoo.co.in 
Dr. Shekhar Srivastava  Shekhar Hospital  Manisha Market, ,Shahpura,-
Bhopal
 
09826052288,0755-2425242,2423242

drshekharbhopal@hotmail.com/shekhar_hospital@rediffmail.com  
Dr. R K Kajala  SP Medical College   Deaprtment of Surgery, ,SP Medical College, -
Bikaner
 
9784642077

 
Dr. Umesh Dutta Sharma  Sri Krishna Hospital  Sri Krishna Hospital, Near Bijori,Lalsoth Road -
Dausa
 
9460563903

 
Dr. Pragnesh Shah  Sushrut Hospital  Sushrut Hospital, Near Baadshah Dairy, ,Mahalaxmi paanch rasta, Paldi-
Ahmadabad
 
9825251564

 
Dr. JG Patel  VS Hospital  Associate professor, Department of Orthopedics, ,Seth Vadilal Sarabhai Hospital, -
Ahmadabad
 
9925038375

jyotish1974 @yahoo.co.in 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 14  
Name of Committee  Approval Status 
Convenient Hospitals Ltd.- Dr. Rakesh Shivhare  Approved 
EC Smt. NHL Municipal Medical College, Ahmedabad - Dr. Jyotish G. Patel  Approved 
Independent Ethics Committe For Research in Human Subjects, Ahmedabad - Dr. Apoorva Chaudhary  Approved 
Independent Ethics Committe For Research in Human Subjects, Ahmedabad - Dr. Ashok Meghwal  Approved 
Independent Ethics Committe For Research in Human Subjects, Ahmedabad - Dr. DK Jindel  Approved 
Independent Ethics Committe For Research in Human Subjects, Ahmedabad - Dr. Minesh Modi  Approved 
Independent Ethics Committe For Research in Human Subjects, Ahmedabad - Dr. Mohan Mantri  Approved 
Independent Ethics Committe For Research in Human Subjects, Ahmedabad - Dr. Narendra Patidar  Approved 
Independent Ethics Committe For Research in Human Subjects, Ahmedabad - Dr. Pragnesh Shah  Approved 
Independent Ethics Committe For Research in Human Subjects, Ahmedabad - Dr. Pritesh Patel  Approved 
Independent Ethics Committe For Research in Human Subjects, Ahmedabad - Dr. Shailesh Shah  Approved 
Independent Ethics Committe For Research in Human Subjects, Ahmedabad - Dr. Shekhar Srivastava  Approved 
Independent Ethics Committe For Research in Human Subjects, Ahmedabad - Dr. Sunil Singh  Approved 
Independent Ethics Committe For Research in Human Subjects, Ahmedabad - Dr. Umesh Dutta Sharma  Approved 
 
Regulatory Clearance Status from DCGI
Modification(s)  
Status 
Approved/Obtained 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  Acute painful soft tissue injury 
 
Intervention / Comparator Agent
Modification(s)  
Type  Name  Details 
Comparator Agent  IBUPROFEN  400 mg three times a day for 7 days 
Intervention  IN-PHARM-002  80 mg three times a day for 7 days 
 
Inclusion Criteria
Modification(s)  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  (1)Patients of either sex between 18 and 60 years of age diagnosed with acute painful soft tissue injury.
(2)Subjects willing to provide written informed consent

In case of female with child bearing potential Surgically sterile or using a medically accepted means of contraception with negative serum pregnancy test 
 
ExclusionCriteria 
Details  (1)Concomitant peptic ulcer, gastrointestinal bleeding and asthma.
(2)Serious heart, blood, renal or hepatic diseases.
(3)Clinically significant abnormalities on physical examination or laboratory tests.
(4)Ongoing use of prohibited medications [i.e. other NSAIDs, opioid analgesics and systemic corticosteroids].
(5)Pregnancy or lactation.
(6)As deemed inappropriate for enrollment by investigating physician due to other reasons.
 
 
Method of Generating Random Sequence
Modification(s)  
Computer generated randomization 
Method of Concealment
Modification(s)  
Not Applicable 
Blinding/Masking
Modification(s)  
Open Label 
Primary Outcome
Modification(s)  
Outcome  TimePoints 
(1) Change in the visual analog scale at endpoint compared to baseline.  At the end of treatment 
 
Secondary Outcome
Modification(s)  
Outcome  TimePoints 
(1)Change in investigators global assessment of pain relief at the endpoint compared to baseline. (2)Percent of patients requiring rescue medication.   At the end of treatment
At every visit  
 
Target Sample Size
Modification(s)  
Total Sample Size="204"
Sample Size from India="204" 
Phase of Trial
Modification(s)  
Phase 3 
Date of First Enrollment (India)
Modification(s)  
23/02/2010 
Date of First Enrollment (Global)  23/02/2010 
Estimated Duration of Trial
Modification(s)  
Years="0"
Months="5"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Nil 
Brief Summary
Modification(s)  
This study has been undertaken to compare the efficacy and safety of IN-PHARM-002 with ibuprofen in patients with acute painful soft tissue injury. It is expected that IN-PHARM-002 would be more effective in reducing pain, safe and well tolerated in comparison to ibuprofen in the treatment of Indian patients with acute painful soft tissue injury. The trial will be conducted in 270 Indian patients of acute painful soft tissue injury within India. Patient enrolment in the study is anticipated to start on 23/02/2010. 

Close